Importantly, through in vitro and in vivo studies, we demonstrated that the combination of DM and BTZ significantly enhanced the inhibitory effect of these two drugs on MM cell viability, promoted MM cell apoptosis, and inhibited tumor growth. The gene discussed is CASC3; the disease is Miyoshi myopathy.